1. Home
  2. AIXI vs LEXX Comparison

AIXI vs LEXX Comparison

Compare AIXI & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIXI
  • LEXX
  • Stock Information
  • Founded
  • AIXI 2001
  • LEXX 2004
  • Country
  • AIXI China
  • LEXX Canada
  • Employees
  • AIXI N/A
  • LEXX N/A
  • Industry
  • AIXI Computer Software: Prepackaged Software
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIXI Technology
  • LEXX Health Care
  • Exchange
  • AIXI Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • AIXI 48.7M
  • LEXX 49.3M
  • IPO Year
  • AIXI 2023
  • LEXX N/A
  • Fundamental
  • Price
  • AIXI $6.75
  • LEXX $3.19
  • Analyst Decision
  • AIXI
  • LEXX Strong Buy
  • Analyst Count
  • AIXI 0
  • LEXX 2
  • Target Price
  • AIXI N/A
  • LEXX $11.00
  • AVG Volume (30 Days)
  • AIXI 234.8K
  • LEXX 100.1K
  • Earning Date
  • AIXI 10-15-2024
  • LEXX 11-18-2024
  • Dividend Yield
  • AIXI N/A
  • LEXX N/A
  • EPS Growth
  • AIXI N/A
  • LEXX N/A
  • EPS
  • AIXI N/A
  • LEXX N/A
  • Revenue
  • AIXI $59,165,259.00
  • LEXX $411,019.00
  • Revenue This Year
  • AIXI $22.85
  • LEXX $82.02
  • Revenue Next Year
  • AIXI $22.70
  • LEXX $95.09
  • P/E Ratio
  • AIXI N/A
  • LEXX N/A
  • Revenue Growth
  • AIXI 22.79
  • LEXX 34.05
  • 52 Week Low
  • AIXI $2.06
  • LEXX $0.85
  • 52 Week High
  • AIXI $24.66
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • AIXI 65.43
  • LEXX 48.73
  • Support Level
  • AIXI $5.00
  • LEXX $2.91
  • Resistance Level
  • AIXI $5.96
  • LEXX $3.39
  • Average True Range (ATR)
  • AIXI 0.94
  • LEXX 0.20
  • MACD
  • AIXI 0.23
  • LEXX 0.00
  • Stochastic Oscillator
  • AIXI 83.60
  • LEXX 56.00

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

Share on Social Networks: